North American COVID-19 Diagnostics Rising Demand and Growth Forecast Through 2033

In 2023, the North American COVID-19 diagnostics market was valued at approximately USD 10,431.2 million. Projections indicate a significant decline, with the market expected to reach USD 2,188.9 million by 2030, reflecting a compound annual growth rate (CAGR) of -20% from 2024 to 2030. Specific data for the year 2032 is not readily available; however, the trend suggests a continued decrease in market size beyond 2030, primarily due to the anticipated reduction in demand for COVID-19 diagnostic tests as the pandemic subsides and vaccination rates increase.

Keyword North American COVID-19 Diagnostics Overview

The North American COVID-19 diagnostics market was valued at approximately USD 10,431.2 million in 2023, reflecting the region's strong response infrastructure and widespread testing initiatives. However, with declining case numbers, high vaccination coverage, and evolving public health priorities, the market is expected to contract significantly. It is projected to shrink to around USD 2,188.9 million by 2030, registering a negative CAGR of -20% from 2024 to 2030. Despite the decline, demand persists in hospitals, long-term care facilities, and for travel and occupational health screening. The focus is gradually shifting toward multiplex diagnostics for respiratory infections, including COVID-19, flu, and RSV. Ongoing technological advancements and preparedness for potential new variants could shape future diagnostic needs in the region.

Request a sample copy of this report at: https://www.omrglobal.com/request-sample/north-american-covid-19-diagnostics-market

Advantages of requesting a Sample Copy of the Report:
1) To understand how our report can bring a difference to your business strategy
2) To understand the analysis and growth rate in your region
3) Graphical introduction of global as well as the regional analysis
4) Know the top key players in the North American COVID-19 Diagnostics with their revenue analysis
5) SWOT analysis, PEST analysis, and Porter's five force analysis

The report further explores the key business players along with their in-depth profiling
Abbott, Roche, Thermo Fisher, Quidel, Bio-Rad, Siemens Healthineers and more.......

North American COVID-19 Diagnostics Market Segments:
◘ By Type: PCR Tests, Antigen Tests, Antibody Tests
◘ By Application: Healthcare, Diagnostics

Report Drivers & Trends Analysis:
The report also discusses the factors driving and restraining North American COVID-19 Diagnostics growth, as well as their specific impact on demand over the forecast period. Also highlighted in this report are growth factors, developments, trends, challenges, limitations, and growth opportunities. This section highlights emerging Keyword North American COVID-19 Diagnostics trends and changing dynamics. Furthermore, the study provides a forward-looking perspective on various factors that are expected to boost the market's overall growth.

Competitive Landscape Analysis:
In any North American COVID-19 Diagnostics research analysis, the main field is competition. This section of the report provides a competitive scenario and portfolio of the Keyword Market's key players. Major and emerging North American COVID-19 Diagnostics players are closely examined in terms of North American COVID-19 Diagnostics share, gross margin, product portfolio, production, revenue, sales growth, and other significant factors. Furthermore, this information will assist players in studying critical strategies employed by North American COVID-19 Diagnostics leaders in order to plan counterstrategies to gain a competitive advantage in the market.

Regional Outlook:
The following section of the report offers valuable insights into different regions and the key players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.

» North America (U.S., Canada, Mexico)
» Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
» Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
» South America (Brazil, Argentina, Rest of SA)
» Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

If you have any special requirements, Request customization: https://www.omrglobal.com/report-customization/north-american-covid-19-diagnostics-market

North American COVID-19 Diagnostics Benefits for Stakeholders:
⏩ The study represents a quantitative analysis of the present Keyword North American COVID-19 Diagnostics trends, estimations, and dynamics of the North American COVID-19 Diagnostics size from 2025 to 2032 to determine the most promising opportunities.
⏩ Porter's five forces study emphasizes the importance of buyers and suppliers in assisting stakeholders to make profitable business decisions and expand their supplier-buyer network.
⏩ In-depth analysis, as well as the North American COVID-19 Diagnostics size and segmentation, help you identify current Keyword North American COVID-19 Diagnostics opportunities.
⏩ The largest countries in each region are mapped according to their revenue contribution to the market.
⏩ The Keyword North American COVID-19 Diagnostics research report gives a thorough analysis of the current status of the Keyword Market's major players.

North American COVID-19 Diagnostics questions answered in the report:
➧ What will the North American COVID-19 Diagnostics development pace of the Keyword Market?
➧ What are the key factors driving the Keyword Market?
➧ Who are the key manufacturers in the North American COVID-19 Diagnostics space?
➧ What are the North American COVID-19 Diagnostics openings, North American COVID-19 Diagnostics hazards,s and North American COVID-19 Diagnostics outline of the Keyword Market?
➧ What are the sales, revenue, and price analysis of the top manufacturers of the Keyword Market?
➧ Who are the distributors, traders, and dealers of Keyword Market?
➧ What are the North American COVID-19 Diagnostics opportunities and threats faced by the vendors in the Keyword Market?
➧ What are deals, income, and value examination by types and utilizations of the Keyword Market?
➧ What are deals, income, and value examination by areas of enterprises in the Keyword Market?

Purchase Now Up to 25% Discount on This Premium Report: https://www.omrglobal.com/buy-now/north-american-covid-19-diagnostics-market?license_type=license-single-user

Reasons To Buy The North American COVID-19 Diagnostics Market Report:
➼ In-depth analysis of the North American COVID-19 Diagnostics on the global and regional levels.
➼ Major changes in North American COVID-19 Diagnostics dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future North American COVID-19 Diagnostics research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in North American COVID-19 Diagnostics dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major North American COVID-19 Diagnostics players and their key methods

Contact Us:
Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Website: www.omrglobal.com
Follow Us: LinkedIn | Twitter

About Orion Market Research
Orion North American COVID-19 Diagnostics Research (OMR) is a North American COVID-19 Diagnostics research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.